Longview Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$221M Sell
1,001,686
-15,264
-2% -$4.22M 3.59% 21
2026
Q1
$300M Sell
1,016,950
-369,818
-27% -$110M 4.26% 14
2025
Q4
$379M Buy
+1,386,768
New +$377M 3.95% 17

Other funds holding CME

Longview Partners's CME Position: Q2 2026 in Review

Longview Partners reduced its CME Group (CME) stake by 1.5% in Q2 2026, selling an estimated $4.22M and leaving 1,001,686 shares worth $221M. The position accounts for 3.59% of the portfolio, ranked #21.

Longview Partners first reported a position in CME in Q4 2025 and has held it in 3 quarters since. The position peaked at $379M in Q4 2025. 1,702 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Longview Partners held 1,001,686 shares of CME Group worth $221M as of Q2 2026.
  • Longview Partners sold 15,264 CME Group shares in Q2 2026, an estimated $4.22M.
  • CME Group made up 3.59% of Longview Partners's portfolio in Q2 2026, its #21 holding.
  • Longview Partners first reported a position in CME Group in Q4 2025 and has held it in 3 quarters since.
  • Longview Partners's CME Group position peaked at $379M in Q4 2025.
  • 1,702 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Longview Partners's 13F filing for Q2 2026, filed 13 Aug 2026.